DNA microarrays in clinical oncology

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Sridhar Ramaswamy, Todd R Golub

Abstract

Aberrant gene expression is critical for tumor initiation and progression. However, we lack a comprehensive understanding of all genes that are aberrantly expressed in human cancer. Recently, DNA microarrays have been used to obtain global views of human cancer gene expression and to identify genetic markers that might be important for diagnosis and therapy. We review clinical applications of these novel tools, discuss some important recent studies, identify promising avenues of research in this emerging field of study, and discuss the likely impact that expression profiling will have on clinical oncology.

References

Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·R A SegalS L Pomeroy
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·L DiatchenkoP D Siebert
Nov 8, 1996·Science·M R Emmert-BuckL A Liotta
Dec 1, 1996·Nature Biotechnology·D J LockhartE L Brown
Jul 14, 1998·Nature Medicine·J KononenO P Kallioniemi
Sep 10, 1998·Nature Genetics·O ErmolaevaM S Boguski
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·M B EisenD Botstein
Jan 23, 1999·Nature Genetics·E SouthernM Shchepinov
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·P TamayoT R Golub
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Feb 26, 2000·Carcinogenesis·J W Gray, C Collins
Mar 4, 2000·Nature Genetics·U ScherfJ N Weinstein
Aug 10, 2000·Cell·R A Young
Aug 30, 2000·Nature·C M PerouD Botstein
Aug 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·M L LeeJ Sklar
Nov 28, 2000·Annual Review of Genetics·A G Knudson
Feb 7, 2001·Proceedings of the National Academy of Sciences of the United States of America·K VirtanevaR Krahe
Feb 7, 2001·Proceedings of the National Academy of Sciences of the United States of America·J B WelshG M Hampton
Feb 22, 2001·Science·J C VenterX Zhu
Feb 24, 2001·The New England Journal of Medicine·I HedenfalkG Sauter
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Apr 5, 2001·The New England Journal of Medicine·J M Goldman, J V Melo
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·V G TusherG Chu
May 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·O MonniA Kallioniemi
May 18, 2001·Nature·B A Ponder
Jun 5, 2001·Nature Reviews. Genetics·J Quackenbush
Jul 27, 2001·The Journal of Surgical Research·J HuangT Yeatman
Aug 9, 2001·Proceedings of the National Academy of Sciences of the United States of America·M TakahashiB T Teh
Aug 24, 2001·Nature·S M DhanasekaranA M Chinnaiyan
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·J E StauntonT R Golub
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Sep 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·M WestJ R Nevins
Nov 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·A BhattacharjeeM Meyerson
Nov 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·M E GarberI Petersen
Dec 4, 2001·Nature Genetics·Scott A ArmstrongStanley J Korsmeyer
Dec 14, 2001·Proceedings of the National Academy of Sciences of the United States of America·S RamaswamyT R Golub

❮ Previous
Next ❯

Citations

Dec 6, 2002·Expert Review of Molecular Diagnostics·Jeffrey S Ross, Geoffrey S Ginsburg
Feb 27, 2003·Proceedings of the National Academy of Sciences of the United States of America·Emily C BaechlerTimothy W Behrens
May 13, 2003·BMC Genomics·Chih Long LiuBradley E Bernstein
Jun 6, 2003·Oncogene·Kristen M CarrJeffrey M Trent
Aug 2, 2003·Clinical and Laboratory Haematology·A P LeveneF E Davies
Feb 19, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ana Fernandez-TeijeiroScott L Pomeroy
Jun 29, 2004·Advances in Anatomic Pathology·Jeffrey S RossGabriel N Hortobagyi
Dec 22, 2004·Current Oncology Reports·Roman RouzierLajos Pusztai
Aug 5, 2005·The Oncologist·Richard J Gilbertson
Sep 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lars Bullinger, Peter J M Valk
Jul 30, 2005·Expert Opinion on Biological Therapy·Donal J BrennanWilliam M Gallagher
Jan 13, 2006·Annual Review of Pharmacology and Toxicology·Meyling H CheokWilliam E Evans
Jun 23, 2006·PLoS Computational Biology·Vinay Varadan, Dimitris Anastassiou
Jul 11, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel W LinPeter S Nelson
Sep 1, 2009·Expert Opinion on Medical Diagnostics·Jeffrey S Ross
Dec 5, 2012·PloS One·Meesbah JiwajiAndrew R Pitt
Jan 23, 2017·Interdisciplinary Sciences, Computational Life Sciences·Hualei KongHua Li
Sep 7, 2002·International Journal of Cancer. Journal International Du Cancer·Barry Iacopetta
Sep 7, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Salman R KhetaniSangeeta N Bhatia
Jan 23, 2004·Cancer Investigation·Jun LuoDavid J Duggan
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H Johnson, Carlos L Arteaga
Oct 12, 2005·Journal of Pediatric Hematology/oncology·Eva BandrésEnrique de Alava
Apr 25, 2003·American Journal of Clinical Pathology·Jeffrey S RossMark Rolfe
Sep 12, 2002·Pharmacogenomics·Marina E Chicurel, Dennise D Dalma-Weiszhausz
Dec 3, 2002·Nature Reviews. Cancer·Nabeel Bardeesy, Ronald A DePinho
May 21, 2005·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Maureen O'SullivanJohn D Pfeifer
Jul 5, 2006·Breast Cancer Research : BCR·Erik H van Beers, Petra M Nederlof
Jul 27, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J Ponce LorenzoJ Montalar Salcedo
Aug 18, 2006·Nature Reviews. Cancer·Andrea H BildJoseph R Nevins
Sep 21, 2004·Nature Reviews. Neuroscience·Paul S MischelStanley F Nelson
May 20, 2008·Seminars in Cutaneous Medicine and Surgery·Manfred Kunz
Dec 29, 2007·The American Journal of Surgical Pathology·Scott J RodigDavid M Dorfman
Dec 31, 2004·Obstetrics and Gynecology·Ambros HuberChristian F Singer
Nov 10, 2005·Proceedings·Marvin J StoneC Allen Stringer
Aug 10, 2007·BMC Bioinformatics·Nigam H ShahMark A Musen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Hematology
Alessandro Fatica, Irene Bozzoni
Endocrine-related Cancer
Neetu Dahiya, Patrice J Morin
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Xinhua LiWei Wu
Expert Review of Molecular Diagnostics
Yuriy Gusev, Daniel J Brackett
© 2022 Meta ULC. All rights reserved